Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:251-257
doi: 10.1161/hc0202.102014
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shinagawa, K.
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shinagawa, K.
Right arrow Articles by Nattel, S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Atrial Fibrillation
*Heart Failure
Related Collections
Right arrow Congestive
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2002;105:251.)
© 2002 American Heart Association, Inc.


Basic Science Reports

Consequences of Atrial Tachycardia-Induced Remodeling Depend on the Preexisting Atrial Substrate

Kaori Shinagawa, MD; Danshi Li, MD PhD; Tack Ki Leung, MD; Stanley Nattel, MD

From the Departments of Medicine (K.S., D.L., S.N.) and Pathology (T.K.L.), Montreal Heart Institute and University of Montreal, Canada.

Reprint requests to Stanley Nattel, MD, 5000 Belanger St E, Montreal, Quebec H1T 1C8, Canada. E-mail nattel{at}icm.umontreal.ca

Background All animal studies of atrial tachycardia (AT) remodeling to date have been performed in normal hearts, but clinical atrial fibrillation (AF) often occurs in the setting of heart disease. This study evaluated the effects of a pathological AF substrate on AT-induced remodeling.

Methods and Results Fourteen control dogs, 12 AT-only dogs (400 bpm for 1 week), 14 congestive heart failure (CHF) dogs (CHF only, ventricular tachypacing, 220 to 240 bpm for 5 weeks), and 13 CHF+AT dogs (ventricular tachypacing-induced CHF, 1 week of AT superimposed on the last week of ventricular tachypacing) were studied for evaluation of AT effects in normal hearts (AT-only versus control dogs) and CHF hearts (CHF+AT versus CHF-only dogs). In normal hearts, AT strongly decreased the effective refractory period (ERP) and abolished ERP rate adaptation, whereas conduction velocity was unaltered. In CHF dogs, AT reduced ERP to a significantly lesser extent, did not alter ERP rate adaptation, and reduced conduction velocity. AT alone increased atrial vulnerability to extrastimuli and prolonged AF. In the presence of CHF, AT had no clear effect on atrial vulnerability but increased the prevalence of prolonged AF.

Conclusions The electrophysiological effects of AT are different in hearts with a CHF-induced pathological substrate for AF than in normal hearts. These findings have potentially important implications for understanding how AF occurring in diseased hearts begets AF.


Key Words: heart failure • remodeling • arrhythmia




This article has been cited by other articles:


Home page
EuropaceHome page
A. Arenal, T. Datino, L. Atea, F. Atienza, E. Gonzalez-Torrecilla, J. Almendral, L. Castilla, P. L. Sanchez, and F. Fernandez-Aviles
Dominant frequency differences in atrial fibrillation patients with and without left ventricular systolic dysfunction
Europace, April 1, 2009; 11(4): 450 - 457.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Bollmann, A. Tveit, D. Husser, M. Stridh, L. Sornmo, P. Smith, and S. B. Olsson
Fibrillatory rate response to candesartan in persistent atrial fibrillation
Europace, October 1, 2008; 10(10): 1138 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Laurent, G. Moe, X. Hu, B. Holub, H. Leong-Poi, J. Trogadis, K. Connelly, D. Courtman, B. H. Strauss, and P. Dorian
Long chain n-3 polyunsaturated fatty acids reduce atrial vulnerability in a novel canine pacing model
Cardiovasc Res, January 1, 2008; 77(1): 89 - 97.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
L. Padeletti, P. Pieragnoli, V. Jentzen, and A. Schuchert
The comorbidity of atrial fibrillation and heart failure: a challenge for electrical therapies
Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I81 - I86.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Cingoz, G. Yanulis, E. Ching, K. Fukamachi, and D. W. Wallick
Use of Conventional Dual Chamber Pacemakers With Custom Lead Adapters to Induce Atrial Fibrillation or Heart Failure in Dogs
Ann. Thorac. Surg., May 1, 2007; 83(5): 1858 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Coutu, D. Chartier, and S. Nattel
Comparison of Ca2+-handling properties of canine pulmonary vein and left atrial cardiomyocytes
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2290 - H2300.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H.-R. Neuberger, U. Schotten, Y. Blaauw, D. Vollmann, S. Eijsbouts, A. van Hunnik, and M. Allessie
Chronic Atrial Dilation, Electrical Remodeling, and Atrial Fibrillation in the Goat
J. Am. Coll. Cardiol., February 7, 2006; 47(3): 644 - 653.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T.-J. Cha, J. R. Ehrlich, L. Zhang, D. Chartier, T. K. Leung, and S. Nattel
Atrial Tachycardia Remodeling of Pulmonary Vein Cardiomyocytes: Comparison With Left Atrium and Potential Relation to Arrhythmogenesis
Circulation, February 15, 2005; 111(6): 728 - 735.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T.-J. Cha, J. R. Ehrlich, L. Zhang, and S. Nattel
Atrial Ionic Remodeling Induced by Atrial Tachycardia in the Presence of Congestive Heart Failure
Circulation, September 21, 2004; 110(12): 1520 - 1526.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Baba, T. Yoshikawa, Y. Fukuda, T. Sugiyama, M. Shimada, M. Akaishi, K. Tsuchimoto, S. Ogawa, and M. Fu
Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy
Eur. Heart J., July 1, 2004; 25(13): 1108 - 1115.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Todd, S. P. Fynn, A. P. Walden, W. J. Hobbs, S. Arya, and C. J. Garratt
Repetitive 4-Week Periods of Atrial Electrical Remodeling Promote Stability of Atrial Fibrillation: Time Course of a Second Factor Involved in the Self-Perpetuation of Atrial Fibrillation
Circulation, March 23, 2004; 109(11): 1434 - 1439.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. K. Collins, E. K. Rhee, J. M. Delucca, M. E. Alexander, L. M. Bevilacqua, C. I. Berul, E. P. Walsh, J. E. Mayer, R. A. Jonas, P. J. del Nido, et al.
Modification to the Fontan procedure for the prophylaxis of intra-atrial reentrant tachycardia: short-term results of a prospective randomized blinded trial
J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 721 - 729.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Sinno, K. Derakhchan, D. Libersan, Y. Merhi, T. K. Leung, and S. Nattel
Atrial Ischemia Promotes Atrial Fibrillation in Dogs
Circulation, April 15, 2003; 107(14): 1930 - 1936.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Shinagawa, Y.-F. Shi, J.-C. Tardif, T.-K. Leung, and S. Nattel
Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs
Circulation, June 4, 2002; 105(22): 2672 - 2678.
[Abstract] [Full Text] [PDF]